Skip to content

Antiretrovirals

1. 
All the following are true regarding emtricitabine, except

2. 
All the following are true regarding efavirenz, except

3. 
All the following are true regarding ritonavir, except

4. 
All the following are true regarding enfuvirtide, except

5. 
All the following are true regarding dolutegravir, except

6. 
All the following are true regarding maraviroc, except

7. 
All the following are true regarding cobicistat, except

8. 
All the following are true regarding antiretroviral therapy, except

9. 
All the following are true regarding post-exposure prophylaxis (PEP) of HIV, except

10. 
All the following are true regarding prophylactic treatment of infants born to HIV-infected mothers, except

Leave a Reply

Your email address will not be published. Required fields are marked *